LifeVantage Corp  

(Public, NASDAQ:LFVN)   Watch this stock  
Find more results for LFVN
-0.15 (-1.44%)
Real-time:   10:32AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.02 - 10.43
52 week 4.66 - 15.97
Open 10.26
Vol / Avg. 27,992.00/139,300.00
Mkt cap 138.67M
P/E 36.58
Div/yield     -
EPS 0.28
Shares 14.03M
Beta 0.97
Inst. own 31%
Nov 2, 2016
Q1 2017 LifeVantage Corp Earnings Release (Estimated) Add to calendar
Oct 14, 2016
LifeVantage Corp Annual Shareholders Meeting (Estimated) - 2:00PM EDT - Add to calendar
Sep 13, 2016
Q4 2016 LifeVantage Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 1.79% 3.67%
Operating margin 6.47% 7.30%
EBITD margin - 8.56%
Return on average assets 9.04% 14.90%
Return on average equity 50.77% 191.03%
Employees 166 -
CDP Score - -


9785 S. Monroe Street, Suite 300
SANDY, UT 84070
United States - Map
+1-801-4329000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


LifeVantage Corporation is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products. The Company's products include Protandim, a dietary supplement that reduces the age-dependent growth in markers of oxidative stress; LifeVantage TrueScience, a line of anti-aging skin care products, which include TrueScience Ultra Gentle Facial Cleanser, TrueScience Perfecting Lotion, TrueScience Eye Corrector Serum and TrueScience Anti-Aging Cream; Canine Health, a pet supplement formulated to combat oxidative stress in dogs, and Axio, an energy drink mix formulated to promote alertness and support mental performance. The Company sells its products to an international network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico and Thailand.

Officers and directors

Darren Jay Jensen President, Chief Executive Officer, Independent Director
Age: 46
Bio & Compensation  - Reuters
Mark R. Jaggi Chief Financial Officer, Treasurer
Age: 40
Bio & Compensation  - Reuters
Robert M. Urban Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Courtland Pearson Senior Vice President of International
Bio & Compensation  - Reuters
Ryan Thompson Senior Vice President - Business Development
Age: 44
Bio & Compensation  - Reuters
Ryan Goodwin Chief Marketing Officer
Bio & Compensation  - Reuters
Michelle Oborn-Virchow Vice President - Human Resources
Age: 34
Bio & Compensation  - Reuters
Justin Rose Chief Sales Officer
Age: 47
Bio & Compensation  - Reuters
Michael A. Beindorff Independent Director
Age: 63
Bio & Compensation  - Reuters
David S. Manovich Independent Director
Age: 63
Bio & Compensation  - Reuters